Business
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.
Pediatric nephrology and cardiology teams continue to seek out Aquadex for safe, precise fluid management in complex casesMINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, announced today that a leading Northeastern U.S. children’s hospital has initiated an Aquadex Ultrafiltration Program. Pediatric nephrology and cardiology teams across the country continue to se
About this update from Nuwellis, Inc.
[{"type":"image","alt":"Nuwellis, Inc.","displaySize":"","headline":null,"caption":"Nuwellis, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":72,"url":"https://media.zenfs.com/en/globenewswire.com/d2460037586c5d451999b7d63383d34b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/epm_zxode7LAVlWVBg62FQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/d2460037586c5d451999b7d63383d34b","width":300,"height":72}},"lazy":false},{"type":"text","content":"Pediatric nephrology and cardiology teams continue to seek out Aquadex for safe, precise fluid management in complex cases","length":122,"tagName":"p"},{"type":"text","content":"MINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, announced today that a leading Northeastern U.S. children’s hospital has initiated an Aquadex Ultrafiltration Program. Pediatric nephrology and cardiology teams across the country continue to seek out the therapy for its minimal extracorporeal volume requirement and reliability in managing fluid-sensitive patients, driving steady growth in Nuwellis’ expanding pediatric market.","length":563,"tagName":"p"},{"type":"text","content":"Aquadex adoption continues to accelerate in high-acuity pediatric settings nationwide. Children’s hospitals are integrating the therapy into care pathways for complex cardiac, cardio-renal, and critical care cases as teams look for controlled, predictable approaches to fluid management. This broader institutional uptake highlights both the clinical value physicians see in Aquadex and the strategic importance of the pediatric market within Nuwellis’ long-term growth plan.","length":475,"tagName":"p"},{"type":"text","content":"“Our growth in pediatrics is being led by the clinicians themselves,” said John Erb, CEO of Nuwellis. “Pediatric nephrology and cardiology teams are seeking out Aquadex because it gives them a level of control and safety they haven’t had with traditional approaches. Their adoption of the therapy is also creating a meaningful and expanding pillar of growth for our business.”","length":376,"tagName":"p"},{"type":"text","content":"With the addition of this new key customer, Aquadex is now utilized across a growing number ...